RxSight, Inc.
RXST
$6.26
-$0.23-3.54%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -41.85% | -16.41% | 12.29% | 40.34% | 43.52% |
| Total Depreciation and Amortization | -8.64% | -30.97% | -23.91% | -26.55% | -15.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 55.68% | 61.33% | 48.06% | 37.19% | 39.27% |
| Change in Net Operating Assets | 46.61% | -1.68% | 21.45% | -79.16% | -0.99% |
| Cash from Operations | 8.47% | 11.11% | 43.22% | 50.30% | 59.26% |
| Capital Expenditure | 29.60% | 42.76% | 29.16% | 32.91% | -13.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 122.07% | 134.89% | 149.58% | -274.52% | -442.14% |
| Cash from Investing | 117.01% | 128.96% | 139.65% | -303.39% | -348.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 57.38% | 43.37% | 99.81% | 99.92% | 99.90% |
| Issuance of Common Stock | -96.94% | -95.46% | -93.13% | 137.98% | 21.67% |
| Repurchase of Common Stock | 56.76% | 56.82% | -25.87% | -25.87% | -235.14% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 79.09% | 70.77% | 73.12% |
| Cash from Financing | -98.49% | -96.95% | -95.48% | 2,621.25% | 100.44% |
| Foreign Exchange rate Adjustments | 133.33% | -45.45% | 1,600.00% | -100.00% | -250.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -54.02% | 88.69% | 1.95% | -121.34% | 421.76% |